Photodynamic therapy in patients with skin metastases of melanoma
https://doi.org/10.24931/2413-9432-2015-4-2-22-25
Abstract
Results of treating 114 skin metastases of melanoma in 21 patients are represented. Melanoma progression with cutaneous metastases after previous treatment was diagnosed in all patients. The method of prolonged photodynamic therapy developed by authors with fotosens administrated intravenously at dose of 0.4 mg/kg of body weight was used in the study. First session of tumor irradiation was performed 2 h after injection of photosensitizer. Patients underwent superfi cial or contact irradiation depending on topography and type of growth of metastatic foci. Course of treatment accounted for 7–10 sessions of photodynamic therapy with 24 h interval, light dose delivered to tumor for one session – 350 J/cm2. Signifi cant clinical effect (complete and partial tumor regression) was obtained in 89% of cases for developed method.
About the Authors
E. V. Filonenko
P.A. Herzen MCRI – branch of FSI « NMRRC» of Russian Ministry of Health, Moscow
Russian Federation
Russian Federation
L. G. Serova
P.A. Herzen MCRI – branch of FSI « NMRRC» of Russian Ministry of Health, Moscow
Russian Federation
Russian Federation
A. N. Urlova
P.A. Herzen MCRI – branch of FSI « NMRRC» of Russian Ministry of Health, Moscow
Russian Federation
Russian Federation
References
1. Konstantinova M.M., Savkova R.F., Demidov L.V. i dr. Otsenka effektivnosti i bezopasnosti fotemustina v monorezhime i v kombinatsii s proizvodnymi platiny (karboplatinom ili isplatinom) pri lechenii disseminirovannoi melanom (Asssessment of effi cacy and safety of fotemustin in monoregimen and in combination with platinum derivates (carboplatin or cisplatin)), Sovremennaya onkologiya, 2009, T. 11, No. 3, pp. 56–62.
2. Fradkin S.Z., Zalutskii I.V. Melanoma kozhi: Prakticheskoe posobie dlya vrachei (Skin melanoma: practice guidelines for physicians), Mn. Belarus', 2000, pp. 221.
3. Demidov L.V., Kharkevich G.Yu. Ad"yuvantnoe lechenie bol'nykh melanomoi kozhi (Adjuvant therapy of patients with skin melanoma), Prakticheskaya onkologiya, 2001, No. 4, pp. 42–46.
4. Nosov D.A. Lekarstvennoe lechenie disseminirovannoi melanomy (Drug therapy for disseminated melanoma), Prakticheskaya onkologiya, 2001, No. 4, pp. 50–55.
5. Nosov D.A., Garin A.M. Vozmozhnosti khimioterapii disseminirovannoi melanomy (Capabilities of chemotherapy of disseminated melanoma), Russkii meditsinskii zhurnal, 2001, T. 9, No. 22, pp. 58–63.
6. Balch C.M., Reintgen D.S., Kirkwood J.M. et al. Cutaneous melanoma. In De Vita V.T. Jr., Hellman S., Rosenberg S.A. (eds): Cancer Principles and Practice of Oncology (ed.5), Philadelphia, PA, Lippincott-Raven, 1997, Vol. 2, pp. 1947–1994.
7. Barchuk A. S. Khirurgicheskoe lechenie melanomy (Surgical treatment of melanoma), Prakticheskaya onkologiya, 2001, No. 4, pp. 30–36.
8. Tilgen W. Malignant melanoma current therapeutic concepts, Oncologie, 2000, Vol. 18, pp. 534–547.
9. Brownstein M.H., Helwig E.B. Patterns of cutaneous metastasis, Arch. Dermatol, 1972, Vol. 105, No. 5, pp. 862–868.
10. Brownstein M.H., Helwig E.B. Metastatic tumors of the skin, Cancer, 1972, Vol. 29, No. 5, pp. 1298–1307.
11. Brownstein M.H., Helwig E.B. Spread of tumors to the skin, Arch. Dermatol, 1973, Vol. 107, No. 1, pp. 80–86.
12. Schwartz R.A. Cutaneous metastatic disease // J. Am. Acad. Dermatol, 1995, No. 33, pp. 161–182.
13. Soyer H.P., Argenziano G., Hofmann-Wellenhof R. et al. I Color Atlas of Melanocyte Lesions of the skin, 2007, pp. 260–264.
14. Savoia P., Fava P., Nardm T. et al. Skin metastases of malignant melanoma: a clinical and prognostic survey, Melanoma Res., 2009, Vol. 19, No. 5, pp. 321–326.
15. Khebif T.P. Kozhnye bolezni: Diagnostika i lechenie (Skin diseases: Diagnosis and treatment), Per. s angl.; Pod obshch. red. Akad. RAMN, prof. A.A. Kubanovoi, M.: MEDpress-inform, 2007, 2-e izd., pp. 466–469.
16. Nivinskaya M.M. Klinika i lechenie melanom (Clinical presentation and treatment of melanoma), M.: Meditsina, 1970, pp. 184.
17. Onkologiya / Pod red. Trapeznikova N.N. i Ekkhardta Sh. (Oncology/ Edited by Trapeznikov NN and Ekkhardt Sh), M.: Meditsina, 1981, pp. 480.
18. Falileev Yu.V. Opukholi kozhi, Klinicheskaya onkologiya / Pod red. Blokhina N.N., Petersona B.E. (Skin tumors, Clinical oncology), M.: Meditsina, 1971, T. 1, pp. 194–217
19. Milton G. W., Shaw KM., McCarthy W.N. Occult primary malignant melanoma factors infl uencing survival, Brit. J. Surg, 1977, Vol. 64, No. 11, pp. 805–808.
20. Lamotkin I.A. Opukholi i opukholepodobnye porazheniya kozhi (Tumors and tumor-like skin lesions), Atlas, BINOM. Laboratoriya znanii, 2006, pp. 152–156.
21. Mackie R.M., Cascinelli K, Kirkwood et al. Osobennosti zabolevaniya i obshchie printsipy vedeniya bol'nykh s melanomoi kozhi (MK) (Features of disease and general principles of management of patients with skin melanoma (SM)), Melanomnaya programma VOZ, 2004, pp. 24.
22. Bagley F.H., Cady В., Zee A. et al. Changes in clinical presentation and management of malignant melanoma, Cancer, 1981, Vol. 47, No. 9, pp. 2126–2134.
23. Stevens M.F., Hickman J.A., Langdon S.P. et al. Antitumor activity and pharmacokinetics in mice of S-carbomoyl-2-methylimidazo 5, 1-d, 2, 3, 5- tetrazin-4(3H)-one (CCRG 81045; MSiB39831), anovel drug with potential as an alternative to dacarbazine, Cancer Res., 1987, Vol. 47, No. 22, pp. 5846–5852.
Review
For citations:
Filonenko E.V., Serova L.G., Urlova A.N. Photodynamic therapy in patients with skin metastases of melanoma. Photodynamic therapy and photodyagnosis. 2015;4(2):22-25. (In Russ.) https://doi.org/10.24931/2413-9432-2015-4-2-22-25
Views:
1803
Email this article 